Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan;90(1):9-14.
doi: 10.1007/s00104-018-0712-4.

[Resection strategies for adrenocortical carcinoma]

[Article in German]
Affiliations
Review

[Resection strategies for adrenocortical carcinoma]

[Article in German]
S Schimmack et al. Chirurg. 2019 Jan.

Abstract

Adrenocortical carcinomas (ACC) are rare and aggressive neoplasms. Due to their high rate of local recurrence and distant metastases (up to 85%) they are associated with a poor survival. The 5‑year survival in ACC patients with lymph node metastasis or local infiltration is 50% and with distant metastasis less than 15%. An R0 resection with locoregional and para-aortic/paracaval lymphadenectomy is the only curative option and reasonable treatment possibility. The treatment of these patients should therefore be planned and carried out in centers. Local recurrences and distant metastases should also be treated with R0 resection when feasible, combined with neoadjuvant/adjuvant chemotherapy and/or radiation. In the case of an asymptomatic non-resectable ACC, debulking operations cannot be recommended. The primary operation can also be done in a minimally invasive procedure if principles of oncological surgery are followed (radical resection, no damage of the tumor capsule, lymphadenectomy), since survival after open and minimally invasive laparoscopic resection was comparable. Palliative resections are only indicated in symptomatic patients.

Keywords: Adrenalectomy; Lymphadenectomy; Oncologic principles; R0 resection; Recurrence.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann Surg Oncol. 1999 Dec;6(8):719-26 - PubMed
    1. Arch Surg. 2001 May;136(5):543-9 - PubMed
    1. Cancer. 2001 Sep 1;92(5):1113-21 - PubMed
    1. World J Surg. 2001 Jul;25(7):891-7 - PubMed
    1. World J Surg. 2001 Jul;25(7):914-26 - PubMed

LinkOut - more resources